Sales and Marketing

Showing 15 posts of 11527 posts found.

Eisai: reform NICE or we’ll pull out of the UK

October 21, 2013 Research and Development, Sales and Marketing Eisai, Hatfield, Hunt, NICE

Eisai has criticised NICE for being too narrow minded on assessing new drugs, and has warned it may pull its …

No closer to Alzheimer’s cure despite rise in research

October 21, 2013 Research and Development, Sales and Marketing Alzheimer's, depression, markram

A scientist charged with developing a digital model of the human brain has said that patients with neurological and neurodegenerative …

The new paradigm in oncology drug marketing

October 21, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Herceptin, Roche, marketing, oncology

Twenty years ago drugs to treat cancer were made up of chemotherapy agents which are essentially ‘blunt tools’ against the …

Mylan hires president of European business

October 21, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, glinka

Mylan has announced that from December Jacek Glinka will be the president of its European business. Glinka served as chief …

Dust settles on US shutdown

October 21, 2013 Medical Communications, Sales and Marketing FDA, Obamacare, PhRMA, shutdown

The FDA has said that it was able to carry out a significant part of its remit during the suspension …

Shire slated following Adderall T-shirt controversy

October 18, 2013 Medical Communications, Sales and Marketing Adderall, EMA, FDA, Shire

A senior doctor and patient welfare advocate has criticised Shire after T-shirts emblazoned with the word ‘Adderall’ appeared for sale …

Roche rules out merger talk

October 18, 2013 Sales and Marketing Cancer, Herceptin, Novartis, Roche, merger

Roche has dismissed talk of merging with fellow Swiss manufacturer Novartis as it revealed its results for the last three …

SCM Pharma appoints new director

October 18, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing SCM Pharma, simon bellamy

Contract development and manufacturing organisation SCM Pharma has expanded its commercial management team with the appointment of a new director. …

Astellas gets NICE nod

October 18, 2013 Sales and Marketing Cancer, NHS, NICE, Xtandi

Astellas Pharma’s new prostate cancer drug Xtandi which has been shown to shrink and kill cancer cells, has been recommended …

Travel ban ambiguity for GSK ‘s former China boss

October 17, 2013 Sales and Marketing China, GSK, bribery, reilly

GlaxoSmithKline has refuted reports that its former chief of Chinese operations is barred from leaving the country while he assists …

Quest starts selling BRCA tests

October 17, 2013 Sales and Marketing BRCA, Myriad, Quest, jolie

Quest Diagnostics has begun selling a genetic test to uncover the risk of hereditary breast cancer, after the US Supreme …

GAVI begins roll-out of cheap HPV vaccine

October 17, 2013 Sales and Marketing GAVI, HPV, Vaccine

For the first time women in parts of the world with the highest cervical cancer death rate will be able …

Director appointed for MediCity

October 17, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing browning, medicity

Former chief executive of Philips Healthcare and Consumer Lifestyle David Browning has been appointed director of MediCity. The new Nottingham-based …

Phase III boost for alirocumab

October 17, 2013 Sales and Marketing LDL, Regeneron, alirocumab

Sanofi and Regeneron Pharmaceuticals are celebrating some upbeat data from their investigational treatment alirocumab, which has proved adept at tackling …

Patients should ‘top up’ NHS costs

October 16, 2013 Sales and Marketing Dixon, England, NHS, NICE, top up

A leading doctor believes that NHS patients must produce top up payments for treatments for non-life threatening conditions. Speaking at …
The Gateway to Local Adoption Series

Latest content